12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
In this article, we discuss 12 most undervalued biotech stocks to buy according to hedge funds.
Mei Pharma Inc. (MEIP)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Anson Investments Amin Nathoo And Moez Kassam | 1,093,188 | $6,340,491 | +27% | 0.78% |
| 2. | Tang Capital Management Kevin C. Tang | 326,084 | $1,891,287 | 0.17% | |
| 3. | Carlson Capital Clint Carlson | 74,000 | $429,200 | -41% | 0.03% |
| 4. | Renaissance Technologies Jim Simons | 150,892 | $875,000 | +5% | 0% |
| 5. | Laurion Capital Management Benjamin A. Smith | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.85 | 48,060 | Large Shareholder | 864,188 | 2023-09-22 | Filing | |
| $6.85 | 32,040 | Large Shareholder | 460,840 | 2023-09-22 | Filing | |
| $6.46 | 33,600 | Large Shareholder | 816,128 | 2023-09-21 | Filing | |
| $6.01 | 120,000 | Large Shareholder | 782,528 | 2023-09-20 | Filing | |
| $6.46 | 22,400 | Large Shareholder | 428,800 | 2023-09-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.03 | 25,000 | Director | 37,500 | 2021-02-23 | Filing | |
| $3.58 | 9,500 | Officer | 24,106 | 2018-08-07 | Filing | |
| $2.21 | 11,000 | Director | 13,250 | 2017-11-27 | Filing | |
| $1.75 | 157,352 | Large Shareholder | 3,163,105 | 2015-11-09 | Filing | |
| $1.85 | 7,560 | Large Shareholder | 3,320,457 | 2015-11-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 611,440 | $3,546,354 | 3.68% | |
| 2. | 389,807 | $2,260,881 | 0% | |
| 3. | 83,318 | $483,245 | 0% | |
| 4. | 51,616 | $299,451 | 0% | |
| 5. | 29,999 | $174,000 | 0% |
News See All
Is MEI Pharma (MEIP) Attractively Priced?
GreenWood Investors LLC, an investment management firm, released its annual 2023 investor letter. A copy of the same can be downloaded here.
11 Cheapest Stocks With Biggest Upside
In this piece, we will take a look at the 11 cheapest stocks with the biggest upside.
MEI Pharma, Inc. (NASDAQ:MEIP) Q4 2023 Earnings Call Transcript
Operator: Good day and welcome to the MEI Fiscal Year-End Earnings Call. My name is Gary and I will be the conference facilitator today. All participants will be in a listen-only mode.
Here's Why GreenWood Invested in MEI Pharma (MEIP)
GreenWood Investors LLC, an investment management firm, released its second quarter 2022 investor letter. A copy of the same can be downloaded here.
MEI Pharma Inc (MEIP): Are Hedge Funds Right About This Stock?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is MEIP A Good Stock To Buy Now?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Top 5 Healthcare Stocks for the Future
Below we present the list of Top 5 Healthcare Stocks for the Future. For the first half of the list and an introduction to Dr.
Hedge Funds Have Never Been This Bullish On MEI Pharma Inc (MEIP)
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Hedge Funds Are Souring On MEI Pharma Inc (MEIP)
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March...
Billionaire Hedge Funds
